News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
10th February 2025 [Sofia, Bulgaria] — Comac Medical is pleased to announce that it has been awarded the EcoVadis...
Introduction Central and Eastern Europe (CEE) has become a leading destination for clinical trials, offering a compelling mix...
29th January 2025 [Sofia, Bulgaria] – Comac Medical is delighted to announce the appointment of Christian Buhlmann as...